43205. Euthyroid hyperthyroxinemia has'been described i n association w i t h TBG excess. W e r e p o r t a 6 112 y r o l d male w i t h h i g h TBG l e v e l s (17 m g l d l ) and h i g h Tq o f 24.5 p g l d l , who also has short s t a t u r e (-3 SO), delayed bone age (BA) o f 2 112 y r and hyper TSH response t o TRH t e s t i n g (max value 52.2 pIUIml). Other data:
v i t a l signs normal, w t a t 5 p e r c e n t i l e , T3-405 p g l d l , FT4= 4.6 n g l d l , FT3=768 p g l d l . Thyroid uptake was 23.7%, T j RU 21.8% ( n l 37.5-47.5%), basal TSH=5.1 pIU/ml. L e f t V e n t r i c u l a r E j e c t i o n Time (LVET) was 0.24 sec ( n l ) . WISC-R I.Q. was n l , sleeping pulse r a t e was n l . T j supplement was s t a r t e d and g r a d u a l l y increased t o 30 pglday. The p a t i e n t was followed a t weekly i n t e r v a l s . No c l i n i c a l signs o f hy erthyroidism occurred.
Serum T4 decreased from 19 t o 6.1 pg/d!, T3 increased t o 640 n g l d l , TRH-TSH t e s t was suppressed (max l e v e l 1.8). LVET r emained normal a t 0.24 sec. Growth v e l o c i t y (GV) increased from 5 cmlyr t o annualized G V o f 9 cmlyr a f t e r 3 mo o f treatment.
Both parents o f t h i s c h i l d had n l t h y r o i d t e s t s .
A 4 112 y r male s i b l i n g i s a f f e c t e d also. H i s TBG=20.6 mgldl, basal TSH=4 pIUIml, Tq=31 p g l d l , h t i s on t h e 10 p e r c e n t i l e (was i n t h e 50 percent i l e i n t h e 1 s t 2 years o f l i f e BA =3 y r . I n summary: 1)these c h i l d r e n A~v e TBG excess consistent w i t h X-linked recessive i n h e r i t a n c e 2)the abnormal TRH s t i m u l a t i o n t e s t , delayed BA, and short stature, improved growth a f t e r T3 supplementation suggest inadequate compensatory mechanisms des p i t e t h e hyperthyroxinemia 3)there can be v a r i a b i l i t y i n expression o f m i l d t h y r o i d i n s u f f i c i e n c y i n conditions o f excess TBG.
THE ONTOGENY bF THE RESPONSE TO GROWTH HORMONE Susan A Berry and Steven k l i g (Sponsored by William Krivit I University of Minnesota Hospitals, Department of Pediatrics, Minneapolis We defined the ontqny of flve hepatic mRNA sequences which are responsive to growth hormone (GH) in juvenile (35 d) hypophysectomlzed rats by NI vltro translation of mRNA sequences and two-d~mensional gel electrophoresis of the 35[~]-methion~ne labeled products Each of the five had a well defined ontqny which did not parallel the ontogeny of hepatic OH receptors or serum GH rialor peri&, for transition of thi: farntly of mRNA sequencej were weaning and puberty The pattern of ontageny for two of the products was slmllar to that observed fur Gh responsive s r u m proteins Induction of relat~ve Gt-deficiency in rat pups by administration of propylth~ourac~l resulted IP alterations in the mRNA sequences suggestive of Gti deficiency however In twelve day old animals GH was much Iws effective in reversing these alterat~ons than in older anlmals Augmentation of normal pups with pituitary dependent hormones (thyroxine.cort~costerone and GH) resulted in changes consistent with an overall Increase in maturation of the liver Th~seffect wasalso observed In non-hormonally responsiveproducts, suggest~ng the change IS not specific to the GH responsive rnRNA family From these observations we conclude that i ) factor, other than OH or GH receptor contept are 01 importar~ce in the expression of GH responsive products in the 12 day old animal .2) the ontcqeny ot GH responsive serum proteins may reflect pretransiational events, 3: Gti and the other pituitary dependent hormones modify the cadenceof expresston of hepatic gene products,4) and that the ability of the liver to respond to @ti 15 an age rependent W e r e p o r t f o u r episodes o f unsustained precocious sexual development accompanied by palpable adnexal masses i n three preschool aged g i r l s .
I n each case s e r i a l p e l v i c ultrasound examinations revealed large ovarian c y s t s which spontaneously disappeared, w i t h r a p i d regression o f precocity, and f a l l i n E2. A t presentation, each g i r l had breast enlargement, l a b i a l hypertrophy w i t h leukorrhea, hyperestrogenized vaginal cytology, and markedly elevated e s t r a d i o l . Two p a t i e n t s had vaginal bleeding. None developed pubic h a i r . Pt. A g e C y s t E~( c y s t ) E2(Postcyst) LH FSH LH(LHRH) SxCourse --crns ng/dl ng/dl mlU/ml mlU/ml rnlU/ml 1 2 y r s 4 34
. I
, l -1 2.2 6 months 2 3yrs 5 33 2.9 \ 1 1 --2 months 2 4yrs 2 7.9 0.5 1.3 i 1 4.2 2 months 3 4yrs 1.5 13.5 0.1 7 5
--4 months P a t i e n t s 2 and 3 had negative c r a n i a l CT scans. P a t i e n t 2 had laparotomy which confirmed t h a t ovaries had returned t o normal. P a t i e n t 3 has been followed f o r 3.5 years without recurrance.
Our data do n o t comment on whether these f o l l i c u l a r c y s t s are t r u l y autonomous since a t l e a s t one p a t i e n t had elevated gonadotrophins, b u t they do suggest t h a t laparotomy and biopsy a r e n o t indicated i n t h i s s i t u a t i o n when good u l t r a s o n i c surv e i l l a n c e i s a v a i l a b l e .
IMMLTNOLOGIC PROFILE OF GROWTH HORMONE DEFICIENT

PATIENTS BEFORE AND AFTER GROWTH HORMONE REPLACEMENT.
Sandra Burchett, Dan Marmer, R u s s e l l Steele, Richard Jacobs, Joycelyn Elders, Stephen Kemp. Dept. of Ped., Univ. of Arkansas f o r Med. Sci. L i t t l e Rock, AR.
Data has been published showing t h a t i n v i t r o exogenously supplied human growth hormone (HGH) can induce a n e o p l a s t i c lymphocytic c e l l l i n e and there i s an increase i n T suppressor and B lymphocytes. We p r o s p e c t i v e l y analyzed HGH e f f e c t s on c h i l dr e n (2-15 years) w i t h HGH deficiency.
Bone age and h e i g h t were ' 2 standard d e v i a t i o n s below normal i n t h i s group. The immunol o g i c p r o f i l e s o f 15 HGH d e f i c i e n t (HGHD) c h i l d r e n were analyzed p r i o r to, one week, and one month a f t e r beginning HGH treatments. Results were compared t o age matched c o n t r o l s (AMC) and t o cons t i t u t i o n a l short s t a t u r e (CSS) c h i l d r e n (HGH > 10 ng/ml. A l l data a r e expressed as means.
x 
t a t i s t i c a l l y s i g n i f i c a n t d i f f e r e n c e i s seen between t h e immunologic p r o f i l e s of HGHD c h i l d r e n p r i o r t o and a f t e r t r e a tment w i t h HGH or from those o f AMC or CSS groups. These data irrd i c a t e no immune aberrations or n e o p l a s t i c p o t e n t i a t i o n i n v i v o o f HGH treatment. ELEVATED TESTOSTERONE (T) LEVELS
The lack of virilization i n newborn males with 38 -HS' D dkficiency has been attributed t o their inability t o synthesize
A 4 steroids, particularly T. However, no steroidal studies using radioimmunoassay technology have been performed i n the newborn with this disorder. A newborn male w i t h pseudovaginal perineoscrotal hypospadias was found t o have a serum 17 hydroxyprogesterone (17 OH P) level of 11,000 ng/dl and a T concentration of 1,095 ng/dl.
The serum 17-hydroxypregnenolone concentration was 21,200 ng/dl and urine steroid determinations revealed a predominance of 16-alpha-85-hydroxysteroids, with a A5 t o A4 steroid ratio of greater than 1, confirming the presence of 3 8-HSD deficiency. Tetrahydro-E, the major urinary cortisol metabolite, was virtually absent. Although the initial serum T concentration was markedly elevated, HCG stimulation revealed a blunted T response w i t h a stimulated AS-androstenediol t o T ratio of 5 t o I. The markedly elevated A 4 steroids, including T, probably resulted from i n utero conversion of A5 steroids by hepatic 38 -HSD activity. ~l t h o u g h~a t i c T production resulted i n elevated serum T concentrations, the lack of urethral fold fusion i n this infant can be explained by the relatively late onset of hepatic enzyme activity when urethral fold fusion can no longer be induced. These findings suggest that A 4 steroids, particularly T and 17 O H P, are elevated i n infants with 3 5-HSD deficiency. Although 17 O H P determinations may serve as a screening test for congenital adrenal hyperplasia, further evaluation is needed to confirm the specific enzyme d~f e c t . W e studied a 21 mo. o l d female w i t h marked growth r e t a r d a t i o n (Ht. 76cm, <2SD, W t . 6.5 Kg <2SD), alopeci~a, small face, micrognathia, pinched nose and sclerodermic l i k e changes o f t h e skin.
Osteoporotic changes were measured by the radiographic photodensitometry of Colbert e t al, and compared t o age and sex norms (25.7 vs 30-40 n l range). P it u i t a r y and t h y r o i d hormones were w i t h i n normal l i m i t s (hGH 1.8 nglml; FSH 3.8 and LH 2.6 mIUlml; P r o l a c t i n 8.0 n g l d l ; TSH luUlml; T4 9.1 and T3 180 n g l d l ) .
Insulin2.0uU/ml, Estrogens 1.7ngldl. DHEA and DHEA s u l f a t e have been reported t o markedly decrease w i t h normal aging. To study them i n progeria we stimul a t e d the p a t i e n t ' s adrenals w i t h 0.125 mg of cortrosyn I.M.(Organon Labs.) and 3 normal c o n t r o l s (Ages 5-9 yr.).
Twenty-four hour u r i n a r y 17KS before were 0.4 and a f t e r 0.5 mgl24 hr. (cont r o l s 0.9 and 3.3); DHEA 0: 35 vs 190+72; 1 hr. 70 vs 256t70; 2 h r 35 vs 279+41 and 12 hr. 35 vs 226+186 n g l d l . DHEA-S 0: undet e c t a b l e = 0 vs 28+14; 1 h r 0 vs 29i21; 2 h r 0 vs 32+14; 12 h r 0 vs 26+20 rncgldl. W e concluded t h a t there i s a marked decrease i n basal and post ACTH s t i m u l a t i o n o f DHEA and DHEA s u l f a t e i n our p r o g e r i a patient.
A d e f i c i e n t y o f adrenal androgens might e x p l a i n the growth r e t a r d a t i o n and osteoporosis seen i n progeria. DHEA has been reported t o have antiaging e f f e c t s I t ' s d e f i c i e n c y i n progeria might not only be important as a biochemical marked f o r the disease b u t might also c o n t r i b u t e t o t h e prematureaging.
